Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.

Skip to the primary content of this page Skip to the footer of this page

Choice Source Therapeutics

Caremark Rx, Inc. (NYSE: CMX) reported today that it completed the acquisition of Choice Source Therapeutics, Inc., a specialty distribution business with a primary focus on providing pharmacy and clinical services for people with hemophilia, for $48.5 million in cash.